June 2023 Newsletter
Message from our Executive Director | Family Support & Medical Conference | Conference Keynote Speaker Announcement | NNPDF In Action | Men’s Health Month | Milestones | Family Assistance & Support Program | Clinical Trial Updates | Community News Updates | The Assistance Fund | Comprehensive Care Centers | Fundraising | Surveys, Studies, & Market Research | NNPDF Membership
Message from our Executive Director
Dear NNPDF Community,
It is hard to believe that our annual Family Support & Medical Conference is less than a month away. All of us at NNPDF are so excited to once again join together to celebrate our community and explore new ways to support all people impacted by all types of Niemann-Pick disease.
This year’s conference marks the 31st anniversary of our special event and we have been hard at work to make sure the agenda caters to everyone. One unique aspect of our conference is the opportunity to engage with leading experts in the field. Industry and medical leaders will share the latest advancements in current research, treatment, and care providing families with the opportunity to gain valuable insights and play an active role in shaping the future of Niemann-Pick disease management. Our keynote speaker, Dr. Klaus Romero, Chief Science Officer, Critical Path Institute (C-Path), will share his experience and offer insights into how leaders can make the drug development process more efficient for communities in critical need of access to treatment. Equally important, our agenda will also features break out sessions led by our Family Services team that can provide important resources for navigating emotional, financial, and physical challenges for caregivers, patients, siblings, and other family members. There will also be many fun activities for children and ample free time to socialize and connect with other families.
The annual Family Conference is also such a special time to help patients and families realize they are not alone. In rare disease communities, the ability to come together in person enables dynamic interactions and the sharing of insights and experiences that can be both emotional and meaningful in so many ways. While our community is strong, the geographical distance that separates us can make in-person connections difficult. For many families, the conference has been their first chance to connect with others who genuinely understand the daily challenges of living with Niemann-Pick disease. These meetings have been transformative for many patients and families, resulting in lifelong friendships and support networks.
We understand that some families may still have concerns about traveling and gathering in-person. We are taking all necessary precautions to ensure the safety and well-being of everyone who attends the meeting this year. For those who cannot attend in person, a virtual option is available.
The conference is just a few weeks away but there is still time to register! I hope you will all plan on joining us to celebrate our community and learn about the latest advances and the best ways to support all people impacted by Niemann-Pick disease. For more information and to register for the conference, please visit: www.nnpdfconf.org.
I look forward to seeing you all very soon!
NNPDF Executive Director
NNPDF Executive Director
There is still time to register for the NNPDF Family Support & Medical Conference!
If you are unable to join us in person but would still like to participate a Virtual Attendance option is available which will allow individuals to watch the general NNPDF Family Support & Medical Conference sessions live from the comfort of their own home. Please select the “Virtual Attendance” option on your registration.
Family Support & Medical Conference
Keynote Address Speaker Announcement
We are pleased to announce Dr. Klaus Romero, Chief Science Officer, Critical Path Institute (C-Path) as our keynote address speaker at our upcoming 31st Annual Family Support & Medical Conference!
Dr. Romero is a clinical pharmacologist and epidemiologist with experience in academic and pharmaceutical clinical research, translational sciences, pharmacometrics, modeling and simulation and pharmacoepidemiology. As a creative clinician scientist, Dr. Romero combines collaborative leadership skills with integrative scientific thinking to make the drug development process more efficient.
We look forward to seeing you in Orlando! Register today!
NNPDF In Action
Men's Health Month
Dan Reynolds, NNPDF member and husband of Dee (NPC), speaks about the importance of Men’s Health Month and support services available at NNPDF.
Family Assistance & Support Program
The NNPDF Family Assistance & Support Program (FASP) provides relief to NNPDF U.S. member families that may be facing a financial obstacle that requires short-term financial assistance. Funding includes but is not limited to, specialized medical equipment and goods, utility bills, adaptive home repairs, home and car repairs, car payments, rent and mortgage payments, and bereavement expenses. Learn more about the NNPDF Family Assistance & Support Program.
Please contact Laurie Turner, Family Services Manager at 920-542-4038 or email@example.com if you have any questions about this program.
Clinical Trial Updates
Clinical trials are currently in progress to study and develop treatments for ASMD and NPC. The NNPDF posts new information regarding clinical trial updates as soon as it is received. Visit our Clinical Trials web page for up to date information on all clinical trials.
Azafaros has announced enrollment of their first patient in Phase 2 RAINBOW Study evaluating AZ-3102 in GM2 and NP-C Patients. The RAINBOW study design enables rapid advancement into the company’s planned Phase 3 efficacy trial. Read the announcement.
Cyclo Therapeutics Update:
Cyclo Therapeutics published positive data from their Phase 2 study of Trappsol Cyclo in the journal of Molecular Genetics and Metabolism Reports. Read the full press release which includes additional commentary from the principal investigator, Dr. Caroline Hastings.
Cyclo Therapeutics Update:
Dr. Caroline Hastings, Global Principal Investigator and Head of the Global Steering Committee for the Phase 3 study TransportNPC™ shares an update on their progress to date to advance this pivotal study in patients with Niemann-Pick Type C1. Read the update.
IntraBio is pleased to announce positive pivotal trial results of IB1001 for the treatment of Niemann-Pick Disease Type C. Read the announcement.
Community News Updates
The NNPDF shares important news and highlights relevant to our Niemann-Pick community as soon as it is received. Visit our Community News web page under the resources tab for up to date information.
Update from Mandos Health: Mandos Health has shared the following June 2023 update with the NNPDF community. Read the complete update.
The Assistance Fund
Struggling with out-of-pocket expenses due to acid sphingomyelinase deficiency (ASMD)? The Assistance Fund is an independent charitable patient assistance organization helping patients and families by providing financial assistance for the cost of treatment and other health-related services. Through its Acid Sphingomyelinase Deficiency Financial Assistance Program, eligible individuals can receive assistance for all FDA-approved treatment for ASMD. Learn more.
Comprehensive Care Centers
NNPDF provides a listing of medical institutions that have experience in caring for and treating Niemann-Pick disorders. This project is supported by our Scientific Advisory Board and we are proud to offer this valuable resource to our families as they search for medical care and treatment. This information has been provided to us by the institutions. Click here to learn more!
If you are connected with a medical team that would like to be added to the NNPDF Comprehensive Care Centers listing, please contact Laurie Turner at firstname.lastname@example.org.
Contributions through fundraising by NNPDF members, families and friends are used to provide services and information to individuals and families affected by NPD, as well as supporting research into finding treatments. Please continue to host and support NPD fundraisers. Awareness Events promote awareness to the general public about Niemann-Pick Disease.
THANK YOU to Paul Fonseca, Patricia Steiger, Kim Whitaker Skinner, and Garland Alvey who recently held Facebook Fundraisers!
If you have recently hosted a fundraising event, send us your photos and we’ll share them and details from your event in upcoming newsletters! Want to host your own fundraiser? Facebook Fundraisers are an easy option! Visit facebook.com/fund/NNPDF to get started!
Surveys, Studies, & Market Research
Be sure to check out our Surveys & Market Research webpage for current survey and study opportunities in the Niemann-Pick disease space. Participating in surveys and studies is important to the advancement of health options for our Niemann-Pick community members. Contact Laurie Turner at email@example.com for any questions.
Enrolling, confirming, or updating your membership will ensure we have accurate information for you and your family. This will help us to continue to provide you with important notifications and updates from the NNPDF.
For assistance contact Laurie at firstname.lastname@example.org or call 920-542-4038